Biophytis SA (BPTSY)
7.62
-0.48
(-5.93%)
USD |
OTCM |
May 22, 16:00
Biophytis Shareholders Equity (Quarterly): -4.264M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.264M |
June 30, 2023 | -3.610M |
June 30, 2023 | -3.610M |
December 31, 2022 | -2.015M |
June 30, 2022 | 3.126M |
June 30, 2022 | 3.126M |
December 31, 2021 | 6.606M |
June 30, 2021 | 7.141M |
June 30, 2021 | 7.141M |
December 31, 2020 | 2.828M |
June 30, 2020 | -4.955M |
Date | Value |
---|---|
June 30, 2019 | -2.957M |
March 31, 2019 | 2.711M |
June 30, 2018 | 18.13M |
June 30, 2018 | 18.13M |
December 31, 2017 | 25.46M |
June 30, 2017 | 8.040M |
June 30, 2017 | 8.040M |
December 31, 2016 | 4.809M |
June 30, 2016 | 9.217M |
June 30, 2016 | 9.217M |
December 31, 2015 | 12.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.955M
Minimum
Jun 2020
7.141M
Maximum
Jun 2021
0.7132M
Average
0.4063M
Median
Shareholders Equity (Quarterly) Benchmarks
DBV Technologies SA | 111.65M |
Cellectis SA | 84.70M |
Genfit SA | 75.11M |
Edap TMS SA | 57.22M |
Adaptimmune Therapeutics PLC | 24.38M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.22M |
Total Liabilities (Quarterly) | 17.52M |